A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
pycmplot: fast, low-memory multi-track circular and linear Manhattan plotting in Python.
Esoh K, Osman F, Fortes-Lima C, Awandare GA, Wonkam A · Bioinform Adv (2026)
Ghana · DOI: 10.1093/bioadv/vbag281
Manhattan plots remain the standard visual summary for genome-wide association studies and other per-variant scans (iHS, FST, XP-EHH). Existing Manhattan visualization tools either lack multi-track support (gwaslab, qmplot, and qqman) or do not provide a Circos-style multi-track circular Manhattan view. CMplot (R) does, but its memory and runtime costs on multi-million-variant inputs are substantial.
We present pycmplot, a Python package for generating multi-track linear and Circos-style circular Manhattan plots from one or more GWAS summary statistics. On a 10-million-variant scan, pycmplot is 5.5× faster and uses ∼5× less memory than CMplot for linear Manhattan plotting, 1.6× faster (and 3× faster with optional pre-filtering) for circular Manhattan, and 7.7× faster for qq rendering. Multi-track comparisons of two summary statistics are 4.5× faster (linear) and 3.5× faster (circular) than CMplot's equivalent mode. Transparent hg18/hg19 → hg38 liftover lets users mix coordinate systems within a single plot, and a lightweight bundle of Ensembl GFF3 gene information files (hg19 and hg38) enables nearest gene annotation.
pycmplot is freely available under the MIT license at https://github.com/esohkevin/pycmplot; and from PyPI (pip install pycmplot). Documentation is at https://pycmplot.readthedocs.io.
Paralogous mutations in the Plasmodium falciparum surface anion channel associate with reduced protection due to sickle hemoglobin.
Forster AJ, Docker J, Healey K, Zhang Z, Trebes A, Buck D, Hamilton WL, Amenga-Etego L, Mentzer AJ, Amambua-Ngwa A, Band G · Cell Rep (2026)
Ghana · DOI: 10.1016/j.celrep.2026.117938
Genome-wide association studies of pathogens can uncover new aspects of infection biology and inform interventions. Here, we sequence Plasmodium falciparum genomes from 831 infections of Gambian children, identifying an association with disease severity on chromosome 1 which replicates in Kenyan infections. We then incorporate previously published data from the Gambia, Ghana, Mali, and Kenya in a meta-analysis of association between parasite variation and host sickle hemoglobin (HbS; N = 6,289), revealing several associations beyond the four previously implicated Plasmodium falciparum sickle-associated loci. Prominent among these are mutations affecting the C-terminal of CLAG3, the major parasite nutrient uptake channel, which are shared between two paralogs and estimated to halve the protective effect of HbS. Further loci, including two members of the FIKK kinase family, are also implicated. Our findings indicate the parasite evolutionary response to HbS is more complex than previously understood, opening new functional and epidemiological questions about this important host-parasite interaction.
Metagenomic Tools as Predictive Approaches to Decipher Soil and Rhizosphere Microbial Communities and Their Functions for Sustainable Agriculture.
Emmanuel Shittu O, Ge J, Babalola OO · Int J Genomics (2026)
South Africa · DOI: 10.1155/ijog/3098615
The increasing demand for resilient and sustainable food production necessitates a comprehensive understanding of rhizosphere microbial communities and their functional roles in enhancing plant health, nutrient acquisition, stress resilience, and crop productivity, thereby supporting food security and sustainable agriculture. However, soil microbiomes are composed of complex and unculturable communities of beneficial microorganisms that drive critical ecosystem functions, which traditional culture methods cannot capture. This limits the understanding of their roles and impacts on plant health and agricultural sustainability. Metagenomic tools have emerged as transformative approaches for characterizing microbial diversity in soil. Therefore, this review presents an overview of how metagenomic techniques can be harnessed to predict microbial community structures and their associated functional potentials, ultimately contributing to the development of resilient farming strategies. Next-generation sequencing and bioinformatics enable metagenomics to analyze microbial genetic material in soil and rhizospheres. This study provides insights into microbial diversity and profiles of key functional genes linked to nutrient availability and soil functions. We discuss the use of metagenomics tools to predict soil health and microbial functions for sustainable agroecosystems, emphasizing predictive models that help farmers optimize yields and minimize environmental impact. This review explores how metagenomics tools in agriculture can serve as a predictive model to transform our understanding of soil-microbe interactions. This advancement can facilitate the formulation of novel, more resilient, productive, and sustainable agricultural systems.
Pleiotropy and eQTL analysis identify shared genetic architecture of lipid traits in African-ancestry populations.
Oyibo K, Zhong M, Adebamowo C, Choudhury A, Fatumo S, Hazelhurst S, Mitchell BD, Ramsay M, Tayo B, Zhang Y, Adebamowo SN · Hum Mol Genet (2026)
South Africa · DOI: 10.1093/hmg/ddag100
Dyslipidemia is a leading modifiable risk factor for cardiovascular disease (CVD), yet the shared genetic architecture of lipid traits remains poorly characterized, particularly in African-ancestry populations who bear a disproportionate CVD burden but are underrepresented in genomic research. We conducted multi-trait meta-analyses of genome-wide association summary statistics for HDL cholesterol, LDL cholesterol, triglycerides, and total cholesterol in 34 039 individuals of African ancestry, comprising 27 289 discovery participants from three continental African cohorts (ACCME, AWI-Gen, and UGR) and 6750 replication participants from the UK Biobank. Multi-trait analysis and eQTL colocalization across metabolic and cardiovascular tissues were then performed to identify shared genetic signals and characterize their tissue-specific regulatory mechanisms. Multi-trait analysis identified 90 genome-wide significant variants. Of these, 43 were novel variants with no prior exact-variant lipid association records. Eight variants across six genomic regions reached genome-wide significance in the multi-trait analysis and 70 of the 90 primary signals remained significant after total cholesterol was excluded. The strongest associations localized to established lipid loci including APOE/NECTIN2/TOMM40 (P = 8.09 × 10-133), CETP (P = 9.44 × 10-108), LIPC (P = 9.42 × 10-51), and LPL (P = 5.79 × 10-22), with 92% of signals replicating in the UK Biobank cohort. eQTL colocalization linked seven lead variants to tissue-specific gene expression and prioritized candidate regulatory genes. Together, these findings characterize shared lipid-associated signals with heterogeneous, trait-dependent effects in continental African populations and provide population-relevant evidence for candidate regulatory mechanisms.
Phylogenetic analysis of the 2025 Ebola outbreak in the Democratic Republic of the Congo.
Amuri-Aziza A, Luakanda-Ndelemo G, Makangara-Cigolo JC, Kinganda-Lusamaki E, Ngandu C, Bula-Loso S, Mossoko M, Tshulo L, Akil-Bandali P, Kitenge-Omasumbu R, Jansen D, Brosius I, Lokilo-Lofiko E, Kimbonza S, Paku-Tshambu P, Ngonda-Tshibinda A, Kuispond-Swar NR, Ayouba A, Nsio J, Mbantshi-Beya JP, Cikaya-Kankolongo F, Ntumba-Tshitenge O, Otshudiema-Otokoye J, Keita M, Mukadi P, Mukadi-Bamuleka D, Tshiani-Mbaya O, Akilimali P, Mulangu S, Quick J, Loman N, Mwamba D, Delaporte E, Hensley LE, Rimoin AW, Wilkinson S, Ariën KK, Peeters M, Ahuka-Mundeke S, Liesenborghs L, Kindrachuk J, Low N, Carroll MW, O'Toole Á, Maes P, Vercauteren K, Muyembe-Tamfum JJ, Kuppalli K, Rambaut A, Wawina-Bokalanga T, Mbala-Kingebeni P · Nat Commun (2026)
Ethiopia · DOI: 10.1038/s41467-026-77542-9
On 4 September 2025, the Ministry of Public Health, Hygiene and Social Welfare officially declared the 16th Ebola disease outbreak in the Democratic Republic of the Congo (DRC). This outbreak ended on 1 December 2025 and occurred in Bulape Health Zone, Kasaï Province, an area with limited access to appropriate healthcare facilities and resources. Here, we describe the probable index patient and molecular investigations of samples obtained from six suspected patients from the initial outbreak phase. We identified Orthoebolavirus zairense (EBOV) in five samples from different patients. In addition, we performed whole-genome sequencing and generated four complete EBOV genomes. These genomes form a well-supported phylogenetic cluster with genomes from the 1976 Yambuku/Mayinga outbreak. This study suggests a likely new zoonotic spillover event from an as-yet unidentified natural reservoir. While the close relationship to 1976 EBOV Yambuku/Mayinga genomes is striking, this poses additional challenges on the comprehension of the animal reservoir species.
Pharmaceutical quality of artemether-lumefantrine in Rwanda's public health supply chain: a cross-sectional post-market surveillance study.
Rutayisire R, Uwimana A, Rujeni N, Ndoricyimpaye EL, Ntirenganya L, Caillet C, Dhorda M, Mutesa L · Malar J (2026)
Rwanda · DOI: 10.1186/s12936-026-06063-z
Substandard and falsified (S&F) antimalarial medicines undermine malaria control efforts across sub-Saharan Africa, with an estimated 19% of antimalarials failing to meet quality standards and contributing to 40,000-160,000 preventable deaths annually. ACTs, particularly artemether-lumefantrine (AL), are the cornerstone of malaria treatment, yet their effectiveness is threatened by poor pharmaceutical quality and emerging drug resistance. This study evaluated the pharmaceutical quality of AL circulating in Rwanda's public health supply chain to assess compliance with international pharmacopeial standards.
A cross-sectional survey was conducted in February 2023 across eight districts representing all five provinces of Rwanda and encompassing both high- and low-malaria transmission settings. A total of 19 samples (3588 AL tablets) were sampled from three supply chain levels: Rwanda Medical Supply (RMS) headquarters and district branches, health centers, and Community Health Workers. Samples underwent comprehensive quality testing at a WHO-recognized laboratory, including visual inspection, tablet weight determination, high-performance liquid chromatography (HPLC) assay for artemether and lumefantrine content (acceptance range: 95.0-105.0%), and dissolution testing using pharmacopeial methods. The study followed Medicine Quality Assessment Reporting Guidelines (MEDQUARG) guidelines for medicine quality surveillance.
All 19 samples (3588 tablets, 100%) met international pharmacopeial quality standards across all testing parameters. Visual inspection revealed no packaging defects, labeling errors, or tablet abnormalities. Tablet weight uniformity complied with specifications for both dispersible tablets (mean: 356.27 mg; range: 355.04-357.65 mg; specification: 339.50-360.50 mg) and regular tablets (mean: 241.63 mg; range: 239.79-242.72 mg). Artemether assay values ranged from 97.3 to 99.4% (mean: 98.7%), while lumefantrine ranged from 97.3 to 104.3% (mean: 99.2%), with all samples meeting the 95.0-105.0% acceptance criteria. Dissolution testing demonstrated 100% compliance for both active pharmaceutical ingredients across all samples.
All AL samples met international quality standards, contrasting with sub-Saharan Africa's 19% failure rate. Rwanda's centralized procurement, regulatory oversight, and WHO-prequalified sourcing demonstrate a replicable model for ensuring antimalarial quality and combating drug resistance.
Pathogenic traits of coagulase-negative Staphylococci and Mammalicoccus isolated from neonatal sepsis blood cultures in low- and middle-income countries.
Aziz J, Sands K, Boostrom I, Thomson K, Zahra R, Iregbu KC, Mazarati JB, Whitelaw A, Walsh TR, Spiller OB · Microb Pathog (2026)
Rwanda · DOI: 10.1016/j.micpath.2026.108863
Coagulase-negative staphylococci (CoNS) are increasingly recognised as neonatal pathogens in low- and middle-income countries (LMICs), yet are often dismissed as contaminants. We characterised the genomic landscape, antimicrobial resistance (AMR), and virulence of 48 CoNS isolates recovered as the sole pathogen from neonates with clinical sepsis across seven hospitals in five LMICs. Whole-genome sequencing determined sequence types, resistomes, and virulomes, whilst virulence was assessed using a Galleria mellonella in vivo model. Species identified included Mammaliicoccus sciuri (n = 19; 40%), S. haemolyticus (n = 15; 31%), S. epidermidis (n = 11; 23%), S. saprophyticus (n = 2), and S. xylosus (n = 1). M. sciuri predominated in early-onset sepsis (63%); S. haemolyticus (87%) and S. epidermidis (64%) dominated late-onset cases. Multidrug resistance (≥3 classes) was pervasive in S. haemolyticus (93%) and S. epidermidis (91%), with 41.7% of all isolates harbouring mecA-positive SCCmec elements. In Galleria, S. haemolyticus induced significantly higher mortality than S. epidermidis and M. sciuri (p < 0.01). Genomically, expanded cap8 capsular gene cassette carriage in S. haemolyticus negatively correlated with pathogenicity (p = 0.011), suggesting extensive encapsulation masks acute toxicity. Conversely, S. epidermidis exhibited a broader pathogenic arsenal (adherence, exoenzymes, Type VII secretion), wherein adherence-gene burden positively correlated with mortality (p = 0.035), whilst biofilm (icaA-D) carriage showed no significant association (p = 0.412). The recovery of these isolates challenges their perception as mere contaminants. Whilst M. sciuri is associated with early-onset disease, the pronounced virulence of S. haemolyticus and the pervasive MDR profiles of both S. haemolyticus and S. epidermidis highlight them as critical, overlooked pathogens in the neonatal unit.
Nebli S, Saadaoui O, Gargouri H, Abid C, Jardak M, Djebali F, Loukil S, Marzoug RB, Jlaiel L, Croze S, Lachuer J, Kharrat N, Mnif S · Front Microbiol (2026)
Tunisia · DOI: 10.3389/fmicb.2026.1841716
The rising global challenge of antimicrobial resistance and biofilm-associated infections necessitates the discovery of novel bioactive compounds. Endophytic fungi, recognized for their metabolic versatility and ecological adaptability, represent a promising, yet underexplored, source of such molecules. This study aimed to comprehensively characterize the biosynthetic potential of Fusarium oxysporum strain 3RR and establish mechanistic links between its genomic architecture, enzymatic capacity, and observed antibiofilm and antibacterial activities.
An integrated genomics-metabolomics approach was employed. Whole-genome sequencing combined Illumina paired-end and Oxford Nanopore long-read technologies, with hybrid assembly via SPAdes. Gene prediction was performed using BRAKER3 followed by functional annotation via InterProScan, eggNOG-mapper, while biosynthetic gene clusters (BGCs) were predicted using antiSMASH v8.0.4. Antibacterial activity was assessed by agar disk diffusion and microdilution, and antibiofilm activity by crystal violet quantification and microscopy. The extract composition was analyzed using Gas Chromatography-Mass Spectrometry (GC-MS).
The assembled genome (41.14 Mb, N50 = 3.52 Mb) was annotated, and predicted to contain 11,738 genes. 36 BGCs were identified, predominantly terpenes, NRPS, and PKS clusters. CAZy analysis revealed a notable CE10 esterase expansion. GC-MS identified 14 major compounds in the extracellular ethyl acetate extract, dominated by 2,4-di-tert-butylphenol (2,4-DTBP, 16.72%), oleic acid (10.14%), and 8-hydroxyisotrichodermin (7.79%). The extract exhibited antibacterial activity against Staphylococcus epidermidis (up to 34 mm inhibition zone) and Escherichia coli, and remarkable antibiofilm effects, inhibiting S. epidermidis biofilm formation by 96.11% and eradicating Staphylococcus aureus biofilms by up to 54.85%, confirmed microscopically.
The study reveals a sophisticated metabolic architecture in F. oxysporum 3RR, driven by CAZy enzymes and secondary metabolite BGCs. CE10 may act as a metabolic interface by facilitating the liberation or transformation of phenolic and lipid-derived compounds, thereby increasing their potential bioavailability. Rather than attributing the observed bioactivity to 2,4-DTBP or oleic acid alone, the present work places these known metabolites within their genomic and ecological context, linking them to the strain's biosynthetic capacity and its plant-endophytic lifestyle.
F. oxysporum 3RR possesses a powerful chemical defense and offense system, positioning this endophytic fungus as a promising source for novel therapeutic agents against microbial biofilms.
Genetic variation in IL-6 rs1800796 and its association with non-Hodgkin lymphoma susceptibility in the Egyptian population.
Shamshoun H, Madkour MM, Elsaid AM, Refaat S, El-Khawaga OY · J Biosci (2026)
Egypt · DOI: 10.1007/s12038-026-00612-z
Non-Hodgkin lymphomas (NHLs) are associated malignancies with different morphological, genetic, immunophenotypic, and clinical characteristics. Research on genetic susceptibility to NHL is needed to identify at-risk groups and define important disease pathways. Interleukins (ILs) are cytokines that play important immunomodulatory roles. IL-6 stimulates IgG production, exerts antiviral effects, and has been linked to various diseases. Research on IL-6 mutations and NHL is important due to the role of IL-6 in immune regulation and cancer pathogenesis; however, direct causative links remain unclear. The purpose of this study was to investigate the association between the IL-6 genetic polymorphism at the rs1800796 locus and the risk of NHL in Egyptians using a case-control study. The study comprised 100 patients diagnosed with NHL and 100 age- and gender-matched healthy individuals. Risk factors for NHL were associated with lower hemoglobin and albumin levels, increased aspartate aminotransferase, and substantial outcomes in kidney function tests. The study found an absence of the CC genotype in NHL patients, whereas it was found in five healthy volunteers, suggesting a weak potential protective association. The GG genotype was found in more patients than healthy individuals (84 vs. 75); however, no significant association was found. The G allele was found to be more dominant in NHL patients than controls (184 vs. 170; P=0.02). These findings suggest that individuals carrying the G allele may be at twice the risk of developing NHL compared with those carrying the C allele (OR=2.02; 95% CI: 1.07-3.85). The study found no significant association between the IL-6 polymorphism and clinical presentation, tumor stage, or relapse status in NHL patients. These results support the use of the IL-6 variation in the diagnosis and genetic screening of NHL but not for therapeutic choices.